Titan Pharmaceuticals Inc.
TTNP | NASDAQ
$2.34
-$0.30 (-11.36%)
At close: Dec 16, 2025, 1:46 PM ET
Fiscal Quarter Period Ending | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 | Q4 2020 Dec 31, 2020 | Q3 2020 Sep 30, 2020 | Q2 2020 Jun 30, 2020 | Q1 2020 Mar 31, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -430K | -803K | -689K | -563K | -790K | -763K | -2.09M | -1.06M | -1.97M | -338K | -1.59M | -1.68M | -2.57M | -2.64M | -2.46M | -2.54M | -2.54M | -1.92M | -1.68M | -2.64M | -3.09M | -4.93M | -4.64M | -5.58M |
Depreciation & Amortization | n/a | n/a | n/a | n/a | n/a | n/a | 3K | 2K | 3K | 27K | 39K | 43K | 45K | 48K | 51K | 52K | 53K | 56K | 57K | 55K | 65K | 99K | 66K | 62K |
Stock-Based Compensation | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 48K | 411K | 264K | 290K | -91K | 541K | 294K | 253K | 182K | 664K | 447K | 248K | 3K | 9K | 79K | -84K |
Other Working Capital | -495K | 7K | -16K | -295K | 400K | 69K | -58K | -489K | -216K | 135K | 138K | -505K | 785K | 96K | 471K | -430K | 178K | -520K | 418K | -398K | -1.1M | 1.15M | -408K | -197K |
Other Non-Cash Items | -295K | n/a | -9K | 304K | -284K | -70K | -1K | -1K | 167K | -523K | 309K | 428K | 450K | 295K | -49K | 51K | 1K | 2K | -4K | -4K | -165K | 146K | 145K | 356K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -166K | -1.21M | -309K | -428K | n/a | n/a | n/a | n/a | n/a | n/a | -661K | n/a | -2.12M | 433K | n/a | 923K |
Change in Working Capital | -678K | 49K | 9K | -304K | 284K | 70K | 23K | 446K | -328K | -202K | 171K | -557K | 583K | 176K | 399K | -780K | 1.22M | -1.07M | -90K | -283K | 737K | 798K | 368K | -885K |
Operating Cash Flow | -1.11M | -754K | -680K | -867K | -506K | -693K | -2.07M | -613K | -2.25M | -1.84M | -1.11M | -1.9M | -1.58M | -1.87M | -1.77M | -2.96M | -1.08M | -2.26M | -1.93M | -2.63M | -4.56M | -3.45M | -3.98M | -5.21M |
Capital Expenditures | n/a | -5K | n/a | n/a | n/a | n/a | n/a | n/a | -2K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -5K | n/a | -18K | n/a | -9K | -444K | -57K | -30K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 506K | 228K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | -3.16M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 506K | 228K | n/a | n/a | n/a | n/a | n/a | n/a | -23K | n/a | n/a | n/a | -540K | n/a | n/a | n/a |
Investing Cash Flow | -3.16M | -5K | n/a | n/a | n/a | n/a | n/a | n/a | 504K | 228K | n/a | n/a | n/a | n/a | n/a | n/a | -5K | n/a | -18K | n/a | -9K | -444K | -57K | -30K |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 2.64M | -89K | -62K | -19K | -62K | n/a | n/a | n/a | n/a | 9.59M | n/a | n/a | n/a | n/a | 3K | 1K | 8.84M | n/a | n/a | n/a | -1.39M | 22K | 1.5M | 6.16M |
Financial Cash Flow | 2.64M | -89K | 1.54M | -19K | -62K | n/a | n/a | n/a | 406K | 9.59M | n/a | n/a | n/a | n/a | 3K | 4.98M | n/a | n/a | n/a | 8.84M | 5.91M | 2.47M | 1.5M | 8.06M |
Net Cash Flow | -1.63M | -848K | 858K | -886K | -568K | -693K | -2.07M | -614K | -1.34M | 7.99M | -1.11M | -1.9M | -1.58M | -1.87M | -1.76M | 2.02M | -1.09M | -2.26M | -1.95M | 6.22M | 1.34M | -1.43M | -2.54M | 2.82M |
Free Cash Flow | -1.11M | -759K | -680K | -867K | -506K | -693K | -2.07M | -613K | -2.25M | -1.84M | -1.11M | -1.9M | -1.58M | -1.87M | -1.77M | -2.96M | -1.09M | -2.26M | -1.95M | -2.63M | -4.57M | -3.89M | -4.04M | -5.24M |
Adj. Free Cash Flow | -1.11M | -759K | -680K | -867K | -506K | -693K | -2.07M | -613K | -2.3M | -2.25M | -1.38M | -2.19M | -1.49M | -2.41M | -2.06M | -3.22M | -1.27M | -2.93M | -2.4M | -2.87M | -4.57M | -3.9M | -4.12M | -5.16M |
Maintenance CapEx | n/a | -5K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -5K | n/a | -18K | n/a | -9K | -411.78K | n/a | n/a |
Growth CapEx | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -2K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -32.22K | -57K | -30K |
Owner Earnings | -1.11M | -759K | -680K | -867K | -506K | -693K | -2.07M | -613K | -2.25M | -1.84M | -1.11M | -1.9M | -1.58M | -1.87M | -1.77M | -2.96M | -1.09M | -2.26M | -1.95M | -2.63M | -4.57M | -3.86M | -3.98M | -5.21M |
Add to Watchlist
Select watchlists to add or remove TTNP